对于那些患有忧郁或非忧郁抑郁症的人来说,甲爆刺激是否有差异性益处?
Gordon Parker1, Gabriela Tavella2, Michael J Spoelma3
1Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia; Gordon Private Hospital, Gordon, Sydney, Australia.
Journal of affective disorders
|January 25, 2024
概括
泰达爆发刺激 (TBS) 在治疗耐药性抑郁症 (TRD) 患者中有效治疗抑郁症症状. 这项研究发现,在TBS辅助治疗中,忧郁型和非忧郁型抑郁症亚型之间的益处没有显著差异.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 耐治疗抑郁症 (TRD) 是一个重大的临床挑战.
- 甲爆刺激 (TBS) 是一种新兴的神经调节技术.
- 区分抑郁症亚型,比如忧郁症与非忧郁症,可以为治疗选择提供信息.
研究的目的:
- 调查TBS作为TRD辅助治疗的疗效.
- 确定TBS是否为忧郁型与非忧郁型抑郁症亚型提供优先利益.
主要方法:
- 一项自然主义研究,涉及52名接受TBS的TRD患者.
- 用四种诊断策略来分类抑郁症亚型.
- 抑郁症症状使用蒙哥马利-斯伯格抑郁症评分尺度 - 自我评估 (MADRS-S) 在基线,治疗中期,治疗结束和六周后期进行评估.
主要成果:
- 从基线到随访期间,TBS显著降低了抑郁症症状.
- 治疗结束时总体应答率为61.5%,随访时为53.7%.
- 忧郁症和非忧郁症组的改善,反应和缓解率在忧郁症和非忧郁症组之间是可比的.
结论:
- TBS是TRD的潜在有效辅助治疗方法.
- 目前的证据表明,TBS的好处并不特定于忧郁或非忧郁抑郁症亚型.
- 需要进一步的研究来完善忧郁症的测量和探索潜在的差异性治疗效应.
相关概念视频
01:30Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
01:23Antidepressant Drugs: MAOIs and Other Agents
234
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
234